Quantum-SI Inc. (QSI) PT Lowered to $1 at Canaccord

Canaccord analyst Kyle Mikson lowered the price target on Quantum-SI Inc. (NASDAQ: QSI) to $1.00 (from $1.50) while maintaining a Hold rating.

The analyst commented: "We reiterate our HOLD rating on Quantum-Si (QSI) shares and lower our price target to $1 from $1.50. After the market close on Wednesday, March 3, the company reported 4Q25 results below our estimates and FactSet consensus. We estimate low-single-digit Platinum instrument sales in the quarter, with gross margin of approximately 27%. Importantly, QSI has largely shifted its focus to the launch of the Proteus platform, framing 2026 as a "transition year." The company announced a $425,000 list price for Proteus, with the launch on track for late-2026. Importantly, QSI provided initial 2026 revenue guidance of less than $1.0 million, reflecting a de-emphasis on Platinum Pro placements as the company prioritizes Proteus adoption over near-term revenue growth. QSI ended 4Q25 with $215.8 million in cash, which should support operations through launch. While we remain constructive on the longer-term opportunity for protein sequencing, we believe meaningful commercial penetration of Proteus will take time, leading us to remain on the sidelines for now."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Aurora Spine settles patent dispute, secures $600K insider loan
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results